Here are relevant reports on : radioligand-therapy-market
-
Gene Transfer Technologies Market by Product (Instruments, Kits, Assays), Mode (Viral (Retrovirus, Adenovirus, AAV), Non-viral (Electroporation, Gene Gun)), Method (In-Vivo, In-vitro), Application, (Gene Therapy, Research) - Global Forecast to 2029
The global gene transfer technologies market, valued at US$3.63 billion in 2023, stood at US$3.73 billion in 2024 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2029, culminating in a forecasted valuation of US$5.93 billion by the end of the period. The increasing usage in vaccine development and applications in cancer immunotherapy; is one of the major factors driving the growth of the gene transfer technologies market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Plasma Fractionation Market by Product (Immunoglobulins [Intravenous, Subcutaneous], Albumin, Protease Inhibitors, VWF), Application (Preclinical, Therapeutics), Therapy (Neurology, Immunology, Hematology, Rheumatology), Region - Global Forecast to 2031
The global plasma fractionation market is projected to reach USD 52.58 billion by 2031, growing at a CAGR of 7.6% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Clinical Trial Services Market by Type (Lab, Monitoring, Contracts, Recruitment, PV, Biostatistics), Phase (I, II, III), Therapy (Oncology, Neurology, Dermatology, CVD), Modality (Biologics, Devices), Delivery Model (FSP, Hybrid) - Global forecast to 2031
The global clinical trial services market is projected to reach USD 97.41 billion by 2031, growing at a CAGR of 8.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Home Healthcare Market by Product (Therapeutic, Testing, Screening, Monitoring, Mobility Care), Service (Nursing, Infusion Therapy, Rehabilitation, Palliative Care), Indication (Cancer, Diabetes, CVD, Respiratory, Wound Care) - Global Forecast to 2030
The global home healthcare market, valued at US$285.3 billion in 2024, stood at US$309.9 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$473.8 billion by the end of the period. This growth is driven by the rising elderly population, which is more prone to chronic conditions such as hypertension, diabetes, and cardiovascular diseases, increasing the need for ongoing care at home.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Animal Stem Cell Therapy Market by Type (Allogeneic, Autologous), Species (Dog, Cat & Horse), End User (Veterinary Hospital, Research Organization) - Global Forecast to 2027
The global animal stem cell therapy market size is projected to reach USD 0.3 billion by 2027 from USD 0.2 million in 2022, at a CAGR of 5.2% during the forecast period. The growth in the cases of various health issues such as arthritis, degenerative joint disorders, and tendon injuries in animals. This factor is encouraging the development of the global animal stem cell therapy market.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017
The market is broadly classified into two segments, namely, diagnostic and therapeutic; the former dominated with about 80.7% share in 2012. Radioisotopes in the diagnostic market are categorized as SPECT and PET. Technetium 99m (Tc-99m) dominated the SPECT radioisotope market in 2012, followed by thallium–201(Tl-201), gallium–67 (Ga-67), and iodine-123 (I-123). SPECT is majorly used in cardiology-related diagnosis; it is poised to grow at a CAGR of 10.2% from 2012 to 2017. The radiopharmaceuticals market in the Asia-Pacific region was valued at $500.8 million in 2012; it is poised to reach $824.9million in 2017 at a CAGR of 10.5%.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
Fill Finish Manufacturing Market by Consumables (PFS [System, Plunger Stoppers, Glass, Polymer], Vials [Bulk, RTU], Vial Stoppers, Cartridges, Cell Therapy Bags), Instruments (Integrated), Type (Automated), Services, Competition - Global Forecast to 2031
The global fill finish manufacturing market is projected to reach USD 30.37 billion by 2031, growing at a CAGR of 9.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Digital Biomarkers Market by Type (Physiological, Vocal, Idiosyncratic), Therapy [Cardio, Onco (Lung, Breast Cancer), Mental Health, Neuro], Application [Clinical Research (Phase IV)], End User (Pharma & Biotech Companies, CROs) – Global Forecast to 2031
The global digital biomarkers market is projected to reach USD 17.73 billion by 2031, growing at a CAGR of 19.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Medical Devices and Supplies Market by Product (Anesthesia, Patient Monitoring, Infusion Pumps, Consumables), Application (Diagnosis, Monitoring, Therapy, Surgical), Animal Type (Companion Animals, Large Animals) - Global Forecast to 2030
The global veterinary medical devices and supplies market, valued at US$2.50 billion in 2024, stood at US$2.66 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2024 to 2030, culminating in a forecasted valuation of US$3.60 billion by the end of the period. The market growth is driven by the rising pet ownership and increasing expenditure on animal healthcare, coupled with the growing prevalence of chronic and infectious diseases in companion and livestock animals.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Hyperbaric Oxygen Therapy Equipment Market by Product (Hyperbaric Oxygen Chambers, Chamber Accessories, Consumables), Application (Injuries, Infections, Insufficiencies), End User - Global Forecast to 2022
The global hyperbaric oxygen therapy equipment market is expected to reach $3.21 Billion by 2022 from $2.26 Billion in 2017, growing at a CAGR of 7.1% from 2017 to 2022. Rising incidence and prevalence of acute and chronic wounds, ready availability of hyperbaric oxygen therapy systems, and growing popularity of leisure and adventure activities are some of the major driving factors driving the growth of the global hyperbaric oxygen therapy equipment market. However, the high cost of treatment and challenges in reimbursement are hindering the growth of this market to a certain extent.
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
